CIK 0001827635 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Veradermics, Inc
Sign in to watch- Ticker
- MANE
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 843304423
- Phone
- 228.372.3376
- Business address
- 470 JAMES STREET, NEW HAVEN, CT, 06513
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $242,788,217
- in 5 filings, $12.0M under 10b5-1 plans
Net −$242,788,217. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- MONTANOVA CAPITAL, LLC −$80.4M Director sold 62% of stake
- ENRIGHT PATRICK G −$75.2M Director sold 22% of stake
- Longitude Capital Partners V, LLC −$75.2M 10% owner sold 22% of stake
- Waldman Reid Alexander −$7.3M Chief Executive Officer sold 28% of stake
- Durso Timothy August −$4.7M Chief Technical Officer sold 36% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-11 | ENRIGHT PATRICK G Director | Sale | −250,000 | $150.38 | $37.6M | 2,350,399 |
| 2026-11-11 | ENRIGHT PATRICK G Director | Sale | −250,000 | $150.38 | $37.6M | 1,803,474 |
| 2026-11-11 | Longitude Capital Partners V, LLC 10% owner | Sale | −250,000 | $150.38 | $37.6M | 2,350,399 |
| 2026-11-11 | Longitude Capital Partners V, LLC 10% owner | Sale | −250,000 | $150.38 | $37.6M | 1,803,474 |
| 2026-09-01 | Hollander David Chief R&D Officer | Grant or award | +9,650 | 9,650 | ||
| 2026-09-01 | Hollander David Chief R&D Officer | Grant or award · Stock Option (Right to Buy) | +19,300 | 19,300 | ||
| 2026-08-20 | MONTANOVA CAPITAL, LLC Director | Option exercise | +149,000 | 3,106,937 | ||
| 2026-08-20 | MONTANOVA CAPITAL, LLC Director | Option exercise | +151,000 | 612,033 | ||
| 2026-08-20 | MONTANOVA CAPITAL, LLC Director | Option exercise · Pre-Funded Warrants | −149,000 | 0 | ||
| 2026-08-20 | MONTANOVA CAPITAL, LLC Director | Option exercise · Pre-Funded Warrants | −151,000 | 0 | ||
| 2026-08-19 | MONTANOVA CAPITAL, LLC Director | Sale | −690,601 | $107.25 | $74.1M | 2,957,937 |
| 2026-08-19 | MONTANOVA CAPITAL, LLC Director | Sale | −59,399 | $107.25 | $6.4M | 461,033 |
| 2026-08-17 | Durso Timothy August Chief Technical Officer | Option exercise 10b5-1 | +3,452 | $12.19 | $42K | 121,642 |
| 2026-08-17 | Durso Timothy August Chief Technical Officer | Sale 10b5-1 | −7,918 | $106.71 | $845K | 113,724 |
| 2026-08-17 | Durso Timothy August Chief Technical Officer | Sale 10b5-1 | −16,306 | $107.52 | $1.8M | 97,418 |
| 2026-08-17 | Durso Timothy August Chief Technical Officer | Sale 10b5-1 | −16,767 | $108.38 | $1.8M | 80,651 |
| 2026-08-17 | Durso Timothy August Chief Technical Officer | Sale 10b5-1 | −2,348 | $109.34 | $257K | 78,303 |
| 2026-08-17 | Durso Timothy August Chief Technical Officer | Sale 10b5-1 | −161 | $111.28 | $18K | 78,142 |
| 2026-08-17 | Durso Timothy August Chief Technical Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −3,452 | 0 | ||
| 2026-08-17 | Waldman Reid Alexander Chief Executive Officer | Option exercise 10b5-1 | +3,452 | $12.19 | $42K | 238,324 |
Page 1 of 6 · 107 trades